SlideShare a Scribd company logo
Neoplasia 2Neoplasia 2
By Suraj DharaBy Suraj Dhara
(MMCH)(MMCH)
CHARACTERISTICS OF BENIGN AND MALIGNANT NEOPLASMS
EPIDEMIOLOGY
CHARACTERISTICS OF BENIGN AND MALIGNANT NEOPLASMS
EPIDEMIOLOGY
ObjectivesObjectives
 Compare and contrast benign and malignant tumors with respect to:
 demarcation from surrounding tissue (capsule, local invasiveness.
 rate of growth
 degree of differentiation (Explain the meaning of differentiation).
 distant spread (metastases).
 Describe the morphologic changes associated with poorly differentiated
tumors; define and understand the usage of the terms anaplasia,
pleomorphism, nuclear atypia, abnormal mitoses and tumor giant cells.
 Understand the clinical significance of invasiveness and metastasis.
 Describe the anatomic pathways utilized by tumors in metastatic
spread. Know which pathways are commonly used by carcinomas
versus sarcomas.
 List some common sites of distant metastases.
 Recognize the epidemiologic data of cancer distribution in regard to
age, race, geographic factors, and genetic backgrounds.
 List some inherited syndromes with a genetic predisposition to cancer.
NeoplasiaNeoplasia
Characteristics of benign and malignant
neoplasms
 Differentiation and anaplasia
 Rate of growth
 Local invasion
 Metastasis
NeoplasiaNeoplasia
1.1. Differentiation and anaplasia:Differentiation and anaplasia:
 Differentiation means : the extent to which
the parenchymal cells of the tumor
resemble their normal counterparts
morphologically and functionally
NeoplasiaNeoplasia
 well differentiated = closely resemble their
normal counterparts
 Moderately differentiated
 Poorly differentiated
 Undifferentiated ( Anaplasia )
NeoplasiaNeoplasia
 Benign tumors = well differentiated
 Malignant tumors =
well differentiated -----> anaplastic
Well differentiated squamous cell CA of skin. The tumor cells are strikingly similar to normal
squamous epithelial cells, with intercellular bridges & nests of keratin pearls (arrow)
Pleomorphic tumor of the skeletal muscle (rhabdomyosarcoma). Note the marked cellular & nuclear
pleomorphism, hyperchromatic nuclei & tumor giant cells.
Anaplastic tumor showing cellular and nuclear variation in size & shape. The prominent cell showing
atypical mitotic figure (arrow).
NeoplasiaNeoplasia
 In the histological examination of a tumor
you should look for :
 Pleomorphism : variation in size
 High nuclear/ cytoplasm ratio ( N/C ratio)
 Hyperchromasia ( dark cell )
 Mitosis ….(abnormal one)
NeoplasiaNeoplasia
Characteristics of benign and malignant neoplasmsCharacteristics of benign and malignant neoplasms
 Differentiation and anaplasiaDifferentiation and anaplasia
 Rate of growthRate of growth
 Local invasionLocal invasion
 MetastasisMetastasis
NeoplasiaNeoplasia
 Rate of growth:Rate of growth:
 Benign tumors:
 grows slowly
 are affected by blood supply, hormonal effects , location
 Malignant tumors :
 grows faster
 Correlate with the level of differentiation
NeoplasiaNeoplasia
Characteristics of benign and malignant neoplasmsCharacteristics of benign and malignant neoplasms
 Differentiation and anaplasiaDifferentiation and anaplasia
 Rate of growthRate of growth
 Local invasionLocal invasion
 MetastasisMetastasis
NeoplasiaNeoplasia
 Local invasion :Local invasion :
 Benign tumors :
 Remain localized
 Cannot invade
 Usually capsulated
 Malignant tumors :
 Progressive invasion
 Destruction
 Usually not capsulated
Fibroadenoma of the breast. The tan coloured encapsulated small tumor is sharply demarcated from
the whitish breast tissue.
Microscopic view of fibroadenoma of the breast.
Cut section of an invasive ductal CA of breast. The lesion is restricted, infiltrating the surrounding
breast substance, and would be stony hard on palpation.
NeoplasiaNeoplasia
Characteristics of benign and malignant neoplasmsCharacteristics of benign and malignant neoplasms
 Differentiation and anaplasiaDifferentiation and anaplasia
 Rate of growthRate of growth
 Local invasionLocal invasion
 MetastasisMetastasis
NeoplasiaNeoplasia
 Metastasis :Metastasis :
 Definition : the development of secondary
implants discontinuous with the primary tumor,
possibly in remote tissues
A liver studded with metastatic growth.
NeoplasiaNeoplasia
 Metastasis :Metastasis :
 Cancers have different ability to metastasize
 Approximately 30% patients present with
clinically evident metastases.
 Generally, the more anaplastic and the larger the
primary tumor, the more likely is metastasis
NeoplasiaNeoplasia
 Metastasis : three pathwaysMetastasis : three pathways
 Lymphatic spread :
 Hematogenous spread :
 Seeding of the body cavities: pleural, peritoneal
cavities and cerebral ventricles
NeoplasiaNeoplasia
 LymphaticLymphatic spread :spread :
 Favored by carcinomas
 Breast carcinoma  axillary lymph nodes
 Lung carcinomas  bronchial lymph nodes
NeoplasiaNeoplasia
 HematogenousHematogenous spread :spread :
 Favored by sarcomas
 Also used by carcinomas
 Veins are more commonly invaded
 The liver and lungs are the most frequently
involved secondary sites
Comparison between a benign tumor (leiomyoma) and a malignant tumor (leiomyosarcoma) of the
same origin.
NeoplasiaNeoplasia
 In the histological examination of a tumor youIn the histological examination of a tumor you
should look for :should look for :
 Pleomorphism : variation in size
 High nuclear/ cytoplasm ratio ( N/C ratio)
 Hyperchromasia ( dark cell )
 Mitosis ….abnormal one
NeoplasiaNeoplasia
 Dysplasia :Dysplasia :
 Definition: a loss in the uniformity of the individual
cells and a loss in their architectural orientation.
 Non-neoplastic
 Occurs mainly in the epithelium
 Dysplastic cells shows a degree of : pleomorphism,
hyperchromasia, increased mitosis and loss of
polarity.
NeoplasiaNeoplasia
 Dysplasia does not mean cancer
 Dyplasia does not necessarily progress to
cancer
 Dysplasia may be reversible
 If dysplastic changes involve the entire
thickness of the epithelium it is called :
CARCINOMA IN-SITU
What’s that ??
NeoplasiaNeoplasia
 Carcinoma in-situCarcinoma in-situ
 Definition: an intraepithelial malignancy in
which malignant cells involve the entire
thickness of the epithelium without penetration
of the basement membrane.
 Applicable only to epithelial neoplasms.
Carcinoma in situ
Low power view shows that epithelium is
entirely replaced by atypical cells. There is no
orderly differentiation of squamous cells. The
basement membrane is intact, & no tumor in
the sub-epithelial stroma.
Carcinoma in situ
High power view of another region shows
failure of normal differentiation, marked nuclear
& cellular pleomorphism, and numerous mitotic
figures extending toward surface.
Dysplasia Features:Dysplasia Features:
 Increased rate of
multiplication.
 Disordered
maturation.
• Nuclear abnormality
– Increased N/C ratio
– Irregular nuclear membrane
– Increased chromatin content
• Cytoplasmic abnormalities due
to failure of normal maturation
DysplasiaDysplasia
Uterine cervixUterine cervix
Mild Dysplasia
Sever Dysplasia
Dysplasia (cervical pap smear)Dysplasia (cervical pap smear)
DysplasiaDysplasia
 Clinical significance:Clinical significance:
 It is a premalignant condition.
 The risk of invasive cancer varies with:
 grade of dysplasia (mild, moderate, sever)
 duration of dysplasia
 site of dysplasia
DysplasiaDysplasia
 Differences between dysplasia and cancer.Differences between dysplasia and cancer.
∗∗lack of invasiveness.lack of invasiveness.
∗∗ReversibilityReversibility
Carcinoma in situCarcinoma in situ
 A true neoplasm with all of the features of
malignant neoplasm except invasiveness
 Displays the cytological features of
malignancy without invasion of the
basement membrane.
Squamous cell CarcinomaSquamous cell Carcinoma
Uterine CervixUterine Cervix
Dysplasia
NeoplasiaNeoplasia
 EpidemiologyEpidemiology
 Will help to discover aetiology
 Planning of preventive measures
 To know what is common and what is rare.
 Development of screening methods for early
diagnosis
Cancer is a leading cause of death worldwide, accounting for an
estimated 9.6 million deaths in 2018.
The most common cancers are:
Lung (2.09 million cases)
Breast (2.09 million cases)
Colorectal (1.80 million cases)
Prostate (1.28 million cases)
Skin cancer (non-melanoma) (1.04 million cases)
Stomach (1.03 million cases)
The most common causes of cancer death are cancers of:
Lung (1.76 million deaths)
Colorectal (862 000 deaths)
Stomach (783 000 deaths)
Liver (782 000 deaths)
Breast (627 000 deaths)
Always check the updates …
https://www.who.int/news-room/fact-sheets/detail/cancer
NeoplasiaNeoplasia
 Factors affecting incidence of cancerFactors affecting incidence of cancer
 Geographic and Environmental
 Age
 Heredity
 Aquired preneoplastic disorders
NeoplasiaNeoplasia
 Factors affecting incidence of cancerFactors affecting incidence of cancer
 Geographic and EnvironmentalGeographic and Environmental
 AgeAge
 HeredityHeredity
 Aquired preneoplastic disordersAquired preneoplastic disorders
NeoplasiaNeoplasia
 Geographic and Environmental factors:Geographic and Environmental factors:
 Rate of stomach carcinoma in Japan is seven
times the rate in North America and Europe.
 Breast carcinoma is five times higher in North
America comparing to Japan
 Liver cell carcinoma is more common in African
populations
NeoplasiaNeoplasia
 Geographic andGeographic and EnvironmentalEnvironmental factors:factors:
 Asbestos : mesothelioma
 Smoking : lung cancer
 Multiple sexual partners: cervical cancer
 Fatty diets : colonic cancer
Please see table for occupational cancers (Robbins)Please see table for occupational cancers (Robbins)
Table No. is not given as the edition of book will keepTable No. is not given as the edition of book will keep
on changing.on changing.
NeoplasiaNeoplasia
 Factors affecting incidence of cancerFactors affecting incidence of cancer
 Geographic and Environmental
 Age
 Heredity
 Aquired preneoplastic disorders
NeoplasiaNeoplasia
 Age:Age:
 Generally, the frequency of cancer increases with
age.
 Most cancer mortality occurs between 55 and 75.
 Cancer mortality is also increased during
childhood
 Most common tumors of children: Leukemia,
tumors of CNS, Lymphomas, soft tissue and bone
sarcomas.
NeoplasiaNeoplasia
 Factors affecting incidence of cancerFactors affecting incidence of cancer
 Geographic and Environmental
 Age
 Heredity
 Aquired preneoplastic disorders
NeoplasiaNeoplasia
 HeredityHeredity
 Autosomal dominant cancer syndromes
 Autosomal Recessive Syndromes of Defective
DNA Repair
 Familial Cancers of Uncertain Inheritance
HeredityHeredity
 Autosomal dominant cancer syndromesAutosomal dominant cancer syndromes
 Inheritance of a single mutant gene greatly
increases the risk of developing neoplasm
 E.g. Retinoblastoma in children :
 40% of Retinoblastomas are familial
 carriers of the gene have 10000 fold increase in the
risk of developing Retinoblastoma
 E.g. multiple endocrine neoplasia
 See table for more example (Robbins)
HeredityHeredity
 Autosomal Recessive Syndromes of DefectiveAutosomal Recessive Syndromes of Defective
DNA RepairDNA Repair ::
 Small group of autosomal recessive disorders
 Characterized by DNA instability
 E.g. xeroderma pigmentosum
HeredityHeredity
 Familial Cancers of Uncertain InheritanceFamilial Cancers of Uncertain Inheritance
 All common types of cancers occur in familial
form
 E.g. breast, colon, ovary, brain
 Familial cancers usually have unique features:
 Start at early age
 Multiple or bilateral
 Two or more relatives
NeoplasiaNeoplasia
 Factors affecting incidence of cancerFactors affecting incidence of cancer
 Geographic and Environmental
 Age
 Heredity
 Aquired preneoplastic disorders
NeoplasiaNeoplasia
 Aquired preneoplastic disorders:Aquired preneoplastic disorders: SomeSome
Clinical conditions that predispose to cancerClinical conditions that predispose to cancer
 Dysplastic bronchial mucosa in smokers lung
carcinoma
 Liver cirrhosis  liver cell carcinoma
 Margins of chronic skin fistula  squamous cell
carcinoma
THANK YOUTHANK YOU

More Related Content

What's hot

MBBS 2nd Year Pathology - Neoplasia : Introduction
MBBS 2nd Year Pathology - Neoplasia : IntroductionMBBS 2nd Year Pathology - Neoplasia : Introduction
MBBS 2nd Year Pathology - Neoplasia : Introduction
Nida Us Sahr
 
Neoplasia
NeoplasiaNeoplasia
Neoplasia
Ladi Anudeep
 
Neoplasia 1
Neoplasia 1 Neoplasia 1
Neoplasia & Carcinogenesis
Neoplasia & CarcinogenesisNeoplasia & Carcinogenesis
Neoplasia & CarcinogenesisMuhammad Helmi
 
L1 nomenclature of tumors
L1 nomenclature of tumorsL1 nomenclature of tumors
L1 nomenclature of tumors
Mohammad Manzoor
 
Tumors and its pathophysiology
Tumors and its pathophysiologyTumors and its pathophysiology
Tumors and its pathophysiology
Koppala RVS Chaitanya
 
Neoplasia basics ! first lecture !
Neoplasia basics ! first lecture !Neoplasia basics ! first lecture !
Neoplasia basics ! first lecture !Ejaz Waris
 
Neoplasia part 1
Neoplasia part 1Neoplasia part 1
Neoplasia part 1
Bahoran Singh Rajput
 
Neoplasia by Dr. Aryan
Neoplasia by Dr. AryanNeoplasia by Dr. Aryan
Neoplasia by Dr. Aryan
Dr. Aryan (Anish Dhakal)
 
Neoplasia by dr,ahmed alshujery
 Neoplasia by dr,ahmed alshujery Neoplasia by dr,ahmed alshujery
Neoplasia by dr,ahmed alshujery
Dr-Ahmed Alshujery
 
NEOPLASIA: TUMOR NOMENCLATURE
NEOPLASIA: TUMOR NOMENCLATURE  NEOPLASIA: TUMOR NOMENCLATURE
NEOPLASIA: TUMOR NOMENCLATURE
Dr. Roopam Jain
 
Neplasia
NeplasiaNeplasia
Neplasia
Jomin George
 
Neoplasia
NeoplasiaNeoplasia
Carcinogenic agents and their cellular interaction
Carcinogenic agents and their cellular interactionCarcinogenic agents and their cellular interaction
Carcinogenic agents and their cellular interaction
regional institute of medical sciences
 
Introduction to oncology
Introduction to oncologyIntroduction to oncology
Introduction to oncology
ABDUL QADEER MEMON
 
General pathology lecture 7 neoplasms
General pathology lecture 7 neoplasmsGeneral pathology lecture 7 neoplasms
General pathology lecture 7 neoplasmsviancksislove
 
Neoplasia introduction
Neoplasia introductionNeoplasia introduction
Neoplasia introduction
Prasad CSBR
 
Metastasis
MetastasisMetastasis
Metastasis
Noel Christian
 
Tumors
TumorsTumors

What's hot (20)

MBBS 2nd Year Pathology - Neoplasia : Introduction
MBBS 2nd Year Pathology - Neoplasia : IntroductionMBBS 2nd Year Pathology - Neoplasia : Introduction
MBBS 2nd Year Pathology - Neoplasia : Introduction
 
Neoplasia
NeoplasiaNeoplasia
Neoplasia
 
Neoplasia 1
Neoplasia 1 Neoplasia 1
Neoplasia 1
 
Neoplasia & Carcinogenesis
Neoplasia & CarcinogenesisNeoplasia & Carcinogenesis
Neoplasia & Carcinogenesis
 
L1 nomenclature of tumors
L1 nomenclature of tumorsL1 nomenclature of tumors
L1 nomenclature of tumors
 
Tumors and its pathophysiology
Tumors and its pathophysiologyTumors and its pathophysiology
Tumors and its pathophysiology
 
Neoplasia basics ! first lecture !
Neoplasia basics ! first lecture !Neoplasia basics ! first lecture !
Neoplasia basics ! first lecture !
 
Neoplasia part 1
Neoplasia part 1Neoplasia part 1
Neoplasia part 1
 
Neoplasia 1
Neoplasia 1Neoplasia 1
Neoplasia 1
 
Neoplasia by Dr. Aryan
Neoplasia by Dr. AryanNeoplasia by Dr. Aryan
Neoplasia by Dr. Aryan
 
Neoplasia by dr,ahmed alshujery
 Neoplasia by dr,ahmed alshujery Neoplasia by dr,ahmed alshujery
Neoplasia by dr,ahmed alshujery
 
NEOPLASIA: TUMOR NOMENCLATURE
NEOPLASIA: TUMOR NOMENCLATURE  NEOPLASIA: TUMOR NOMENCLATURE
NEOPLASIA: TUMOR NOMENCLATURE
 
Neplasia
NeplasiaNeplasia
Neplasia
 
Neoplasia
NeoplasiaNeoplasia
Neoplasia
 
Carcinogenic agents and their cellular interaction
Carcinogenic agents and their cellular interactionCarcinogenic agents and their cellular interaction
Carcinogenic agents and their cellular interaction
 
Introduction to oncology
Introduction to oncologyIntroduction to oncology
Introduction to oncology
 
General pathology lecture 7 neoplasms
General pathology lecture 7 neoplasmsGeneral pathology lecture 7 neoplasms
General pathology lecture 7 neoplasms
 
Neoplasia introduction
Neoplasia introductionNeoplasia introduction
Neoplasia introduction
 
Metastasis
MetastasisMetastasis
Metastasis
 
Tumors
TumorsTumors
Tumors
 

Similar to NEOPLASIA 2

Neoplasia - Patholgy
Neoplasia - Patholgy Neoplasia - Patholgy
Neoplasia - Patholgy
Jonathan Bondes
 
Characteristics of neoplasms
Characteristics of neoplasmsCharacteristics of neoplasms
Characteristics of neoplasms
Mohammad Manzoor
 
Neoplasia
NeoplasiaNeoplasia
Neoplasia
Suraj Dhara
 
CANCER & TUMOURS.pptx
CANCER & TUMOURS.pptxCANCER & TUMOURS.pptx
CANCER & TUMOURS.pptx
HamdaIdirisodowa
 
Surgical oncology ( malignancies )
Surgical oncology  ( malignancies )Surgical oncology  ( malignancies )
Surgical oncology ( malignancies )
Hristo Rahman
 
Neoplasia- cancer related presentation part2
Neoplasia- cancer related presentation part2Neoplasia- cancer related presentation part2
Neoplasia- cancer related presentation part2
MeMyself84
 
Cancer invasion and metastasis
Cancer invasion and metastasisCancer invasion and metastasis
Cancer invasion and metastasis
Nilesh Kucha
 
Neoplasm - basic of oncology
Neoplasm - basic of oncologyNeoplasm - basic of oncology
Neoplasm - basic of oncology
Nahar Kamrun
 
neoplasia2.pdf
neoplasia2.pdfneoplasia2.pdf
neoplasia2.pdf
YasminZeynu
 
Neoplasia
NeoplasiaNeoplasia
Neoplasia
Aamir Ali
 
Neoplasia,Growth,definition,Differentiation, .ppt
Neoplasia,Growth,definition,Differentiation, .pptNeoplasia,Growth,definition,Differentiation, .ppt
Neoplasia,Growth,definition,Differentiation, .ppt
ziyadwarraich127
 
Epidemiology of neoplasma
Epidemiology of neoplasmaEpidemiology of neoplasma
Epidemiology of neoplasma
imrana tanvir
 
Taniya slide share
Taniya slide shareTaniya slide share
Taniya slide share
Taniya M S
 
NEOPLASIA: Clinical Features of Tumors, Grading and Staging & Laboratory Diag...
NEOPLASIA: Clinical Features of Tumors, Grading and Staging & Laboratory Diag...NEOPLASIA: Clinical Features of Tumors, Grading and Staging & Laboratory Diag...
NEOPLASIA: Clinical Features of Tumors, Grading and Staging & Laboratory Diag...
Dr. Roopam Jain
 
Manik crc final
Manik crc finalManik crc final
Manik crc final
manik mandal
 
UME_HemOnc_CancerInstruction for resident 21112022.pptx
UME_HemOnc_CancerInstruction for resident 21112022.pptxUME_HemOnc_CancerInstruction for resident 21112022.pptx
UME_HemOnc_CancerInstruction for resident 21112022.pptx
MyThaoAiDoan
 
Assignment on NEOPLASIA
Assignment on NEOPLASIA Assignment on NEOPLASIA
Assignment on NEOPLASIA
Tahir Ramzan
 
Cancer biology b7 4 lecures
Cancer biology b7 4 lecuresCancer biology b7 4 lecures
Cancer biology b7 4 lecures
Cooper Man
 
Carcinoma colon-and-management
Carcinoma colon-and-managementCarcinoma colon-and-management
Carcinoma colon-and-managementshiv kishor
 
01 NEOPLASIA.pptx
01 NEOPLASIA.pptx01 NEOPLASIA.pptx
01 NEOPLASIA.pptx
RahmatGul12
 

Similar to NEOPLASIA 2 (20)

Neoplasia - Patholgy
Neoplasia - Patholgy Neoplasia - Patholgy
Neoplasia - Patholgy
 
Characteristics of neoplasms
Characteristics of neoplasmsCharacteristics of neoplasms
Characteristics of neoplasms
 
Neoplasia
NeoplasiaNeoplasia
Neoplasia
 
CANCER & TUMOURS.pptx
CANCER & TUMOURS.pptxCANCER & TUMOURS.pptx
CANCER & TUMOURS.pptx
 
Surgical oncology ( malignancies )
Surgical oncology  ( malignancies )Surgical oncology  ( malignancies )
Surgical oncology ( malignancies )
 
Neoplasia- cancer related presentation part2
Neoplasia- cancer related presentation part2Neoplasia- cancer related presentation part2
Neoplasia- cancer related presentation part2
 
Cancer invasion and metastasis
Cancer invasion and metastasisCancer invasion and metastasis
Cancer invasion and metastasis
 
Neoplasm - basic of oncology
Neoplasm - basic of oncologyNeoplasm - basic of oncology
Neoplasm - basic of oncology
 
neoplasia2.pdf
neoplasia2.pdfneoplasia2.pdf
neoplasia2.pdf
 
Neoplasia
NeoplasiaNeoplasia
Neoplasia
 
Neoplasia,Growth,definition,Differentiation, .ppt
Neoplasia,Growth,definition,Differentiation, .pptNeoplasia,Growth,definition,Differentiation, .ppt
Neoplasia,Growth,definition,Differentiation, .ppt
 
Epidemiology of neoplasma
Epidemiology of neoplasmaEpidemiology of neoplasma
Epidemiology of neoplasma
 
Taniya slide share
Taniya slide shareTaniya slide share
Taniya slide share
 
NEOPLASIA: Clinical Features of Tumors, Grading and Staging & Laboratory Diag...
NEOPLASIA: Clinical Features of Tumors, Grading and Staging & Laboratory Diag...NEOPLASIA: Clinical Features of Tumors, Grading and Staging & Laboratory Diag...
NEOPLASIA: Clinical Features of Tumors, Grading and Staging & Laboratory Diag...
 
Manik crc final
Manik crc finalManik crc final
Manik crc final
 
UME_HemOnc_CancerInstruction for resident 21112022.pptx
UME_HemOnc_CancerInstruction for resident 21112022.pptxUME_HemOnc_CancerInstruction for resident 21112022.pptx
UME_HemOnc_CancerInstruction for resident 21112022.pptx
 
Assignment on NEOPLASIA
Assignment on NEOPLASIA Assignment on NEOPLASIA
Assignment on NEOPLASIA
 
Cancer biology b7 4 lecures
Cancer biology b7 4 lecuresCancer biology b7 4 lecures
Cancer biology b7 4 lecures
 
Carcinoma colon-and-management
Carcinoma colon-and-managementCarcinoma colon-and-management
Carcinoma colon-and-management
 
01 NEOPLASIA.pptx
01 NEOPLASIA.pptx01 NEOPLASIA.pptx
01 NEOPLASIA.pptx
 

More from Suraj Dhara

SHOCK
SHOCKSHOCK
ACUTE INFLAMMATION
ACUTE INFLAMMATIONACUTE INFLAMMATION
ACUTE INFLAMMATION
Suraj Dhara
 
EXAMINATION OF SWELLING
EXAMINATION OF SWELLING EXAMINATION OF SWELLING
EXAMINATION OF SWELLING
Suraj Dhara
 
PAIN : HISTORY TAKING
PAIN : HISTORY TAKINGPAIN : HISTORY TAKING
PAIN : HISTORY TAKING
Suraj Dhara
 
MANAGEMENT OF BREAST CARCINOMA
MANAGEMENT OF BREAST CARCINOMAMANAGEMENT OF BREAST CARCINOMA
MANAGEMENT OF BREAST CARCINOMA
Suraj Dhara
 
DISEASE AND DENGUE
DISEASE AND DENGUEDISEASE AND DENGUE
DISEASE AND DENGUE
Suraj Dhara
 
THE VESTIGIALS
THE VESTIGIALSTHE VESTIGIALS
THE VESTIGIALS
Suraj Dhara
 
STAPHYLOCOCCUS
STAPHYLOCOCCUSSTAPHYLOCOCCUS
STAPHYLOCOCCUS
Suraj Dhara
 
PNEUMOCOCCUS
PNEUMOCOCCUSPNEUMOCOCCUS
PNEUMOCOCCUS
Suraj Dhara
 
SALMONELLA
SALMONELLASALMONELLA
SALMONELLA
Suraj Dhara
 
PAIN : PATHOPHYSIOLOGY
PAIN : PATHOPHYSIOLOGYPAIN : PATHOPHYSIOLOGY
PAIN : PATHOPHYSIOLOGY
Suraj Dhara
 
EPISTAXIS
EPISTAXISEPISTAXIS
EPISTAXIS
Suraj Dhara
 
NASAL POLYP
NASAL POLYPNASAL POLYP
NASAL POLYP
Suraj Dhara
 
FORENSIC MEDICINE MCQS
FORENSIC MEDICINE MCQSFORENSIC MEDICINE MCQS
FORENSIC MEDICINE MCQS
Suraj Dhara
 
AMYLOIDOSIS
AMYLOIDOSISAMYLOIDOSIS
AMYLOIDOSIS
Suraj Dhara
 
RABIES (RHABDOVIRUS)
RABIES (RHABDOVIRUS)RABIES (RHABDOVIRUS)
RABIES (RHABDOVIRUS)
Suraj Dhara
 
ANATOMY OF EXTERNAL EAR
ANATOMY OF EXTERNAL EARANATOMY OF EXTERNAL EAR
ANATOMY OF EXTERNAL EAR
Suraj Dhara
 
ANATOMY OF LARYNX
ANATOMY OF LARYNXANATOMY OF LARYNX
ANATOMY OF LARYNX
Suraj Dhara
 
CONCEPTS OF HEALTH AND DISEASE
CONCEPTS OF HEALTH AND DISEASECONCEPTS OF HEALTH AND DISEASE
CONCEPTS OF HEALTH AND DISEASE
Suraj Dhara
 
LOW BIRTH WEIGHT (ACTIONS TAKEN BY BMOH)
LOW BIRTH WEIGHT (ACTIONS TAKEN BY BMOH)LOW BIRTH WEIGHT (ACTIONS TAKEN BY BMOH)
LOW BIRTH WEIGHT (ACTIONS TAKEN BY BMOH)
Suraj Dhara
 

More from Suraj Dhara (20)

SHOCK
SHOCKSHOCK
SHOCK
 
ACUTE INFLAMMATION
ACUTE INFLAMMATIONACUTE INFLAMMATION
ACUTE INFLAMMATION
 
EXAMINATION OF SWELLING
EXAMINATION OF SWELLING EXAMINATION OF SWELLING
EXAMINATION OF SWELLING
 
PAIN : HISTORY TAKING
PAIN : HISTORY TAKINGPAIN : HISTORY TAKING
PAIN : HISTORY TAKING
 
MANAGEMENT OF BREAST CARCINOMA
MANAGEMENT OF BREAST CARCINOMAMANAGEMENT OF BREAST CARCINOMA
MANAGEMENT OF BREAST CARCINOMA
 
DISEASE AND DENGUE
DISEASE AND DENGUEDISEASE AND DENGUE
DISEASE AND DENGUE
 
THE VESTIGIALS
THE VESTIGIALSTHE VESTIGIALS
THE VESTIGIALS
 
STAPHYLOCOCCUS
STAPHYLOCOCCUSSTAPHYLOCOCCUS
STAPHYLOCOCCUS
 
PNEUMOCOCCUS
PNEUMOCOCCUSPNEUMOCOCCUS
PNEUMOCOCCUS
 
SALMONELLA
SALMONELLASALMONELLA
SALMONELLA
 
PAIN : PATHOPHYSIOLOGY
PAIN : PATHOPHYSIOLOGYPAIN : PATHOPHYSIOLOGY
PAIN : PATHOPHYSIOLOGY
 
EPISTAXIS
EPISTAXISEPISTAXIS
EPISTAXIS
 
NASAL POLYP
NASAL POLYPNASAL POLYP
NASAL POLYP
 
FORENSIC MEDICINE MCQS
FORENSIC MEDICINE MCQSFORENSIC MEDICINE MCQS
FORENSIC MEDICINE MCQS
 
AMYLOIDOSIS
AMYLOIDOSISAMYLOIDOSIS
AMYLOIDOSIS
 
RABIES (RHABDOVIRUS)
RABIES (RHABDOVIRUS)RABIES (RHABDOVIRUS)
RABIES (RHABDOVIRUS)
 
ANATOMY OF EXTERNAL EAR
ANATOMY OF EXTERNAL EARANATOMY OF EXTERNAL EAR
ANATOMY OF EXTERNAL EAR
 
ANATOMY OF LARYNX
ANATOMY OF LARYNXANATOMY OF LARYNX
ANATOMY OF LARYNX
 
CONCEPTS OF HEALTH AND DISEASE
CONCEPTS OF HEALTH AND DISEASECONCEPTS OF HEALTH AND DISEASE
CONCEPTS OF HEALTH AND DISEASE
 
LOW BIRTH WEIGHT (ACTIONS TAKEN BY BMOH)
LOW BIRTH WEIGHT (ACTIONS TAKEN BY BMOH)LOW BIRTH WEIGHT (ACTIONS TAKEN BY BMOH)
LOW BIRTH WEIGHT (ACTIONS TAKEN BY BMOH)
 

Recently uploaded

Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
MIRIAMSALINAS13
 
Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
RaedMohamed3
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
siemaillard
 
Sectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdfSectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdf
Vivekanand Anglo Vedic Academy
 
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptxMARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
bennyroshan06
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
Celine George
 
Cambridge International AS A Level Biology Coursebook - EBook (MaryFosbery J...
Cambridge International AS  A Level Biology Coursebook - EBook (MaryFosbery J...Cambridge International AS  A Level Biology Coursebook - EBook (MaryFosbery J...
Cambridge International AS A Level Biology Coursebook - EBook (MaryFosbery J...
AzmatAli747758
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
Jisc
 
How to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS ModuleHow to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS Module
Celine George
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
Celine George
 
How to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERPHow to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERP
Celine George
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
Pavel ( NSTU)
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
Vivekanand Anglo Vedic Academy
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
beazzy04
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
Thiyagu K
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
EugeneSaldivar
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
Sandy Millin
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
Atul Kumar Singh
 

Recently uploaded (20)

Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
 
Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
 
Sectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdfSectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdf
 
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptxMARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
 
Cambridge International AS A Level Biology Coursebook - EBook (MaryFosbery J...
Cambridge International AS  A Level Biology Coursebook - EBook (MaryFosbery J...Cambridge International AS  A Level Biology Coursebook - EBook (MaryFosbery J...
Cambridge International AS A Level Biology Coursebook - EBook (MaryFosbery J...
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
 
How to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS ModuleHow to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS Module
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
 
How to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERPHow to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERP
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
 

NEOPLASIA 2

  • 1. Neoplasia 2Neoplasia 2 By Suraj DharaBy Suraj Dhara (MMCH)(MMCH) CHARACTERISTICS OF BENIGN AND MALIGNANT NEOPLASMS EPIDEMIOLOGY CHARACTERISTICS OF BENIGN AND MALIGNANT NEOPLASMS EPIDEMIOLOGY
  • 2. ObjectivesObjectives  Compare and contrast benign and malignant tumors with respect to:  demarcation from surrounding tissue (capsule, local invasiveness.  rate of growth  degree of differentiation (Explain the meaning of differentiation).  distant spread (metastases).  Describe the morphologic changes associated with poorly differentiated tumors; define and understand the usage of the terms anaplasia, pleomorphism, nuclear atypia, abnormal mitoses and tumor giant cells.  Understand the clinical significance of invasiveness and metastasis.  Describe the anatomic pathways utilized by tumors in metastatic spread. Know which pathways are commonly used by carcinomas versus sarcomas.  List some common sites of distant metastases.  Recognize the epidemiologic data of cancer distribution in regard to age, race, geographic factors, and genetic backgrounds.  List some inherited syndromes with a genetic predisposition to cancer.
  • 3. NeoplasiaNeoplasia Characteristics of benign and malignant neoplasms  Differentiation and anaplasia  Rate of growth  Local invasion  Metastasis
  • 4. NeoplasiaNeoplasia 1.1. Differentiation and anaplasia:Differentiation and anaplasia:  Differentiation means : the extent to which the parenchymal cells of the tumor resemble their normal counterparts morphologically and functionally
  • 5. NeoplasiaNeoplasia  well differentiated = closely resemble their normal counterparts  Moderately differentiated  Poorly differentiated  Undifferentiated ( Anaplasia )
  • 6. NeoplasiaNeoplasia  Benign tumors = well differentiated  Malignant tumors = well differentiated -----> anaplastic
  • 7. Well differentiated squamous cell CA of skin. The tumor cells are strikingly similar to normal squamous epithelial cells, with intercellular bridges & nests of keratin pearls (arrow)
  • 8. Pleomorphic tumor of the skeletal muscle (rhabdomyosarcoma). Note the marked cellular & nuclear pleomorphism, hyperchromatic nuclei & tumor giant cells.
  • 9. Anaplastic tumor showing cellular and nuclear variation in size & shape. The prominent cell showing atypical mitotic figure (arrow).
  • 10. NeoplasiaNeoplasia  In the histological examination of a tumor you should look for :  Pleomorphism : variation in size  High nuclear/ cytoplasm ratio ( N/C ratio)  Hyperchromasia ( dark cell )  Mitosis ….(abnormal one)
  • 11. NeoplasiaNeoplasia Characteristics of benign and malignant neoplasmsCharacteristics of benign and malignant neoplasms  Differentiation and anaplasiaDifferentiation and anaplasia  Rate of growthRate of growth  Local invasionLocal invasion  MetastasisMetastasis
  • 12. NeoplasiaNeoplasia  Rate of growth:Rate of growth:  Benign tumors:  grows slowly  are affected by blood supply, hormonal effects , location  Malignant tumors :  grows faster  Correlate with the level of differentiation
  • 13. NeoplasiaNeoplasia Characteristics of benign and malignant neoplasmsCharacteristics of benign and malignant neoplasms  Differentiation and anaplasiaDifferentiation and anaplasia  Rate of growthRate of growth  Local invasionLocal invasion  MetastasisMetastasis
  • 14. NeoplasiaNeoplasia  Local invasion :Local invasion :  Benign tumors :  Remain localized  Cannot invade  Usually capsulated  Malignant tumors :  Progressive invasion  Destruction  Usually not capsulated
  • 15. Fibroadenoma of the breast. The tan coloured encapsulated small tumor is sharply demarcated from the whitish breast tissue.
  • 16. Microscopic view of fibroadenoma of the breast.
  • 17. Cut section of an invasive ductal CA of breast. The lesion is restricted, infiltrating the surrounding breast substance, and would be stony hard on palpation.
  • 18. NeoplasiaNeoplasia Characteristics of benign and malignant neoplasmsCharacteristics of benign and malignant neoplasms  Differentiation and anaplasiaDifferentiation and anaplasia  Rate of growthRate of growth  Local invasionLocal invasion  MetastasisMetastasis
  • 19. NeoplasiaNeoplasia  Metastasis :Metastasis :  Definition : the development of secondary implants discontinuous with the primary tumor, possibly in remote tissues
  • 20. A liver studded with metastatic growth.
  • 21. NeoplasiaNeoplasia  Metastasis :Metastasis :  Cancers have different ability to metastasize  Approximately 30% patients present with clinically evident metastases.  Generally, the more anaplastic and the larger the primary tumor, the more likely is metastasis
  • 22. NeoplasiaNeoplasia  Metastasis : three pathwaysMetastasis : three pathways  Lymphatic spread :  Hematogenous spread :  Seeding of the body cavities: pleural, peritoneal cavities and cerebral ventricles
  • 23. NeoplasiaNeoplasia  LymphaticLymphatic spread :spread :  Favored by carcinomas  Breast carcinoma  axillary lymph nodes  Lung carcinomas  bronchial lymph nodes
  • 24. NeoplasiaNeoplasia  HematogenousHematogenous spread :spread :  Favored by sarcomas  Also used by carcinomas  Veins are more commonly invaded  The liver and lungs are the most frequently involved secondary sites
  • 25. Comparison between a benign tumor (leiomyoma) and a malignant tumor (leiomyosarcoma) of the same origin.
  • 26. NeoplasiaNeoplasia  In the histological examination of a tumor youIn the histological examination of a tumor you should look for :should look for :  Pleomorphism : variation in size  High nuclear/ cytoplasm ratio ( N/C ratio)  Hyperchromasia ( dark cell )  Mitosis ….abnormal one
  • 27. NeoplasiaNeoplasia  Dysplasia :Dysplasia :  Definition: a loss in the uniformity of the individual cells and a loss in their architectural orientation.  Non-neoplastic  Occurs mainly in the epithelium  Dysplastic cells shows a degree of : pleomorphism, hyperchromasia, increased mitosis and loss of polarity.
  • 28. NeoplasiaNeoplasia  Dysplasia does not mean cancer  Dyplasia does not necessarily progress to cancer  Dysplasia may be reversible  If dysplastic changes involve the entire thickness of the epithelium it is called : CARCINOMA IN-SITU
  • 30. NeoplasiaNeoplasia  Carcinoma in-situCarcinoma in-situ  Definition: an intraepithelial malignancy in which malignant cells involve the entire thickness of the epithelium without penetration of the basement membrane.  Applicable only to epithelial neoplasms.
  • 31. Carcinoma in situ Low power view shows that epithelium is entirely replaced by atypical cells. There is no orderly differentiation of squamous cells. The basement membrane is intact, & no tumor in the sub-epithelial stroma. Carcinoma in situ High power view of another region shows failure of normal differentiation, marked nuclear & cellular pleomorphism, and numerous mitotic figures extending toward surface.
  • 32.
  • 33. Dysplasia Features:Dysplasia Features:  Increased rate of multiplication.  Disordered maturation. • Nuclear abnormality – Increased N/C ratio – Irregular nuclear membrane – Increased chromatin content • Cytoplasmic abnormalities due to failure of normal maturation
  • 35. Dysplasia (cervical pap smear)Dysplasia (cervical pap smear)
  • 36. DysplasiaDysplasia  Clinical significance:Clinical significance:  It is a premalignant condition.  The risk of invasive cancer varies with:  grade of dysplasia (mild, moderate, sever)  duration of dysplasia  site of dysplasia
  • 37. DysplasiaDysplasia  Differences between dysplasia and cancer.Differences between dysplasia and cancer. ∗∗lack of invasiveness.lack of invasiveness. ∗∗ReversibilityReversibility
  • 38. Carcinoma in situCarcinoma in situ  A true neoplasm with all of the features of malignant neoplasm except invasiveness  Displays the cytological features of malignancy without invasion of the basement membrane.
  • 39. Squamous cell CarcinomaSquamous cell Carcinoma Uterine CervixUterine Cervix Dysplasia
  • 40. NeoplasiaNeoplasia  EpidemiologyEpidemiology  Will help to discover aetiology  Planning of preventive measures  To know what is common and what is rare.  Development of screening methods for early diagnosis
  • 41.
  • 42.
  • 43. Cancer is a leading cause of death worldwide, accounting for an estimated 9.6 million deaths in 2018. The most common cancers are: Lung (2.09 million cases) Breast (2.09 million cases) Colorectal (1.80 million cases) Prostate (1.28 million cases) Skin cancer (non-melanoma) (1.04 million cases) Stomach (1.03 million cases) The most common causes of cancer death are cancers of: Lung (1.76 million deaths) Colorectal (862 000 deaths) Stomach (783 000 deaths) Liver (782 000 deaths) Breast (627 000 deaths) Always check the updates … https://www.who.int/news-room/fact-sheets/detail/cancer
  • 44. NeoplasiaNeoplasia  Factors affecting incidence of cancerFactors affecting incidence of cancer  Geographic and Environmental  Age  Heredity  Aquired preneoplastic disorders
  • 45. NeoplasiaNeoplasia  Factors affecting incidence of cancerFactors affecting incidence of cancer  Geographic and EnvironmentalGeographic and Environmental  AgeAge  HeredityHeredity  Aquired preneoplastic disordersAquired preneoplastic disorders
  • 46. NeoplasiaNeoplasia  Geographic and Environmental factors:Geographic and Environmental factors:  Rate of stomach carcinoma in Japan is seven times the rate in North America and Europe.  Breast carcinoma is five times higher in North America comparing to Japan  Liver cell carcinoma is more common in African populations
  • 47.
  • 48. NeoplasiaNeoplasia  Geographic andGeographic and EnvironmentalEnvironmental factors:factors:  Asbestos : mesothelioma  Smoking : lung cancer  Multiple sexual partners: cervical cancer  Fatty diets : colonic cancer Please see table for occupational cancers (Robbins)Please see table for occupational cancers (Robbins) Table No. is not given as the edition of book will keepTable No. is not given as the edition of book will keep on changing.on changing.
  • 49. NeoplasiaNeoplasia  Factors affecting incidence of cancerFactors affecting incidence of cancer  Geographic and Environmental  Age  Heredity  Aquired preneoplastic disorders
  • 50. NeoplasiaNeoplasia  Age:Age:  Generally, the frequency of cancer increases with age.  Most cancer mortality occurs between 55 and 75.  Cancer mortality is also increased during childhood  Most common tumors of children: Leukemia, tumors of CNS, Lymphomas, soft tissue and bone sarcomas.
  • 51. NeoplasiaNeoplasia  Factors affecting incidence of cancerFactors affecting incidence of cancer  Geographic and Environmental  Age  Heredity  Aquired preneoplastic disorders
  • 52. NeoplasiaNeoplasia  HeredityHeredity  Autosomal dominant cancer syndromes  Autosomal Recessive Syndromes of Defective DNA Repair  Familial Cancers of Uncertain Inheritance
  • 53. HeredityHeredity  Autosomal dominant cancer syndromesAutosomal dominant cancer syndromes  Inheritance of a single mutant gene greatly increases the risk of developing neoplasm  E.g. Retinoblastoma in children :  40% of Retinoblastomas are familial  carriers of the gene have 10000 fold increase in the risk of developing Retinoblastoma  E.g. multiple endocrine neoplasia  See table for more example (Robbins)
  • 54. HeredityHeredity  Autosomal Recessive Syndromes of DefectiveAutosomal Recessive Syndromes of Defective DNA RepairDNA Repair ::  Small group of autosomal recessive disorders  Characterized by DNA instability  E.g. xeroderma pigmentosum
  • 55. HeredityHeredity  Familial Cancers of Uncertain InheritanceFamilial Cancers of Uncertain Inheritance  All common types of cancers occur in familial form  E.g. breast, colon, ovary, brain  Familial cancers usually have unique features:  Start at early age  Multiple or bilateral  Two or more relatives
  • 56. NeoplasiaNeoplasia  Factors affecting incidence of cancerFactors affecting incidence of cancer  Geographic and Environmental  Age  Heredity  Aquired preneoplastic disorders
  • 57. NeoplasiaNeoplasia  Aquired preneoplastic disorders:Aquired preneoplastic disorders: SomeSome Clinical conditions that predispose to cancerClinical conditions that predispose to cancer  Dysplastic bronchial mucosa in smokers lung carcinoma  Liver cirrhosis  liver cell carcinoma  Margins of chronic skin fistula  squamous cell carcinoma

Editor's Notes

  1. Cervical SC carcinoma - infiltrating